(Q80836755)
Statements
Bispecific minibodies targeting HER2/neu and CD16 exhibit improved tumor lysis when placed in a divalent tumor antigen binding format (English)
Lillian S Shahied
Yong Tang
R Katherine Alpaugh
Robert Somer
Dana Greenspon
Louis M Weiner
7 October 2004